Hemoglobin and Iron Metabolism Practice Questions

Q: A 25-year-old patient presents with cyanosis and is diagnosed with methemoglobinemia. What is the underlying biochemical mechanism responsible for this condition?

Oxidation of Fe2+ to Fe3+ in hemoglobin. ***Oxidation of Fe2+ to Fe3+ in hemoglobin*** - **Methemoglobinemia** occurs when the **ferrous iron (Fe2+)** in the heme group of hemoglobin is oxidized to its **ferric state (Fe3+)**. - **Ferric iron** cannot bind oxygen, leading to a functional anemia and **cyanosis**. *Increased synthesis of hemoglobin* - This condition would typically lead to **polycythemia**, an increase in red blood cell count and hemoglobin, not cyanosis due to impaired oxygen binding. - Increased hemoglobin synthesis would generally enhance oxygen-carrying capacity, which is the opposite of what is observed in methemoglobinemia. *Reduction of Fe3+ to Fe2+ in hemoglobin* - This process is the normal mechanism by which **methemoglobin reductase enzymes** convert methemoglobin back to functional hemoglobin. - An effective reduction of **Fe3+ to Fe2+** would actually prevent or resolve methemoglobinemia, rather than cause it. *Decreased oxygen affinity of hemoglobin* - While methemoglobin does not bind oxygen, a condition of generally **decreased oxygen affinity** (e.g., due to a right shift in the oxygen-hemoglobin dissociation curve) can be caused by factors like **2,3-BPG** or acidosis, but it does not directly explain the formation of methemoglobin. - Decreased oxygen affinity would lead to oxygen release in tissues but not necessarily to the characteristic slate-gray cyanosis seen with methemoglobin, which is due to the non-functional ferric iron.

Q: A mutation leads to a significant decrease in the cooperativity of hemoglobin for oxygen binding. Which allosteric regulator's interaction is most likely disrupted?

2,3-Bisphosphoglycerate. ***2,3-Bisphosphoglycerate*** - **2,3-BPG** binds to an **allosteric site** (pocket formed by the beta subunits) of deoxyhemoglobin, stabilizing the **tense (T) state** and reducing its affinity for oxygen. - A mutation disrupting 2,3-BPG binding would impair the normal allosteric regulation of the T↔R state transition, **decreasing cooperativity** by preventing proper stabilization of the low-affinity T-state. - This is the primary physiological allosteric regulator whose interaction, when disrupted, would specifically decrease cooperativity. *Carbon dioxide* - **Carbon dioxide** primarily affects hemoglobin's oxygen affinity by forming **carbamates** with the N-termini of globin chains and by influencing pH (Bohr effect). - While CO2 is an allosteric regulator, its direct impact on the cooperativity mechanism is less pronounced compared to 2,3-BPG's specific role in modulating the T↔R state transition. *Hydrogen ions* - **Hydrogen ions** (protons) decrease hemoglobin's oxygen affinity by binding to specific amino acid residues, stabilizing the **tense (T) state** (the **Bohr effect**). - Although H+ is an allosteric regulator, a mutation specifically causing decreased cooperativity points more directly to 2,3-BPG, which has the most significant role in modulating the sigmoidal binding curve. *Carbon monoxide* - **Carbon monoxide** binds **competitively to the heme iron active site** (NOT an allosteric regulatory site) with an affinity 200-250 times higher than oxygen. - While CO binding does abolish cooperativity by locking hemoglobin in a high-affinity state, this occurs through **direct competitive inhibition** at the oxygen binding site, not through disruption of an allosteric regulator's interaction. - The question specifically asks about allosteric regulator disruption, making this incorrect despite its effect on cooperativity.

Q: A patient with jaundice has elevated unconjugated bilirubin levels. Which enzyme is most likely deficient?

Glucuronyl transferase. ***Glucuronyl transferase*** - This enzyme is responsible for **conjugating bilirubin** with glucuronic acid, converting **unconjugated (indirect) bilirubin** into **conjugated (direct) bilirubin**. - A deficiency in glucuronyl transferase would lead to an accumulation of **unconjugated bilirubin**, causing **jaundice**. *Heme oxygenase* - This enzyme breaks down **heme** into **biliverdin**, which is then converted to bilirubin. - A deficiency would lead to *decreased* bilirubin production, not an *increase* in unconjugated bilirubin. *Biliverdin reductase* - This enzyme converts **biliverdin** into **unconjugated bilirubin**. - A deficiency would impair the production of bilirubin from biliverdin, thus *decreasing* unconjugated bilirubin levels. *Heme synthase* - This enzyme is involved in the final step of **heme synthesis**, inserting iron into protoporphyrin. - A deficiency would primarily affect **heme production** and could lead to **porphyrias** or **anemia**, not elevated unconjugated bilirubin.

Q: Which pigment is responsible for the greenish-black color of neonatal stool?

Biliverdin. ***Biliverdin*** - **Biliverdin** is a green pigment formed from the breakdown of heme before it is converted to bilirubin, and it is responsible for the greenish-black color of **meconium**. - The presence of this pigment in the stool indicates the passage of **meconium**, the first stool of a newborn. *Urochrome* - **Urochrome** is responsible for the yellow color of **urine**, not stool. - It is a pigment derived from **bilirubin** that is excreted by the kidneys. *Stercobilin* - **Stercobilin** is responsible for the characteristic **brown color of adult feces**. - It is formed when **bilirubin** is metabolized by bacteria in the intestine. *Bilirubin (yellow pigment)* - **Bilirubin** is typically a **yellow-orange pigment**, not greenish-black. - While bilirubin is the precursor to stercobilin, its yellow form is more associated with **jaundice** when present in high concentrations.

Q: What is the approximate daily iron requirement for a healthy Indian male?

17 mg. ***17 mg*** - The **Indian Council of Medical Research (ICMR)** recommends approximately **17 mg/day** of iron for adult Indian males to account for the predominantly **vegetarian diet** in India. - Indian diets are rich in **phytates, tannins, and dietary fiber** which significantly reduce iron bioavailability (non-heme iron absorption is only 5-10% compared to 15-25% for heme iron). - This higher recommendation ensures adequate iron absorption to maintain **hemoglobin synthesis** and prevent iron deficiency despite lower bioavailability. *10 mg* - This is the recommendation for populations with predominantly **non-vegetarian diets** (like Western countries) where heme iron from meat has higher bioavailability. - For the **Indian context**, this amount would be **insufficient** given the lower bioavailability of iron from plant-based sources. - While adequate for Western populations, it does not account for India-specific dietary patterns. *35 mg* - This is a **therapeutic dose** used for treating iron deficiency anemia or during pregnancy, not a routine daily requirement. - Such high doses are prescribed under medical supervision for specific clinical conditions and could lead to **gastrointestinal side effects** or iron overload with chronic use. *5 mg* - This amount is **grossly insufficient** for any adult male population and would lead to **negative iron balance** and eventual iron deficiency. - Daily iron losses through desquamation, sweat, and GI tract are approximately 1 mg, requiring adequate dietary intake to maintain iron homeostasis.

Q: What is the normal range of daily fecal urobilinogen excretion in healthy adults?

40-280 mg. ***40-280 mg*** - This range represents the **standard reference range** for daily fecal urobilinogen excretion in healthy adults, as cited in **Harper's Biochemistry** and **Vasudevan Biochemistry**. - **Urobilinogen** is a breakdown product of **bilirubin** formed by intestinal bacteria, with most being oxidized to **stercobilin** (brown pigment) in feces. - This is the **most commonly accepted range** in Indian medical textbooks and examination references. *20-40 mg* - This range is **significantly too low** for normal daily fecal urobilinogen excretion. - Values this low might suggest **decreased bile production**, **cholestasis**, **impaired gut flora activity**, or **antibiotic use** affecting intestinal bacteria. *100-200 mg* - While this falls within the normal range, it is **too narrow** and does not encompass the full variability seen in healthy individuals. - It excludes valid normal values below 100 mg and above 200 mg, making it an incomplete representation of the normal range. *50-300 mg* - This is an **alternative range** cited in some international references and is close to being correct. - However, **40-280 mg** is the **more precise and standard range** taught in Indian medical curricula and is preferred in competitive exam contexts (NEET PG, INI-CET). - The difference reflects slight variations in laboratory methods and population studies.

Q: Heme is synthesized from ?

Glycine + succinyl CoA. ***Glycine + succinyl CoA*** - Heme biosynthesis begins with the condensation of **glycine** and **succinyl CoA** to form **δ-aminolevulinic acid (ALA)**, catalyzed by **ALA synthase (ALAS)**. - This initial reaction is the **rate-limiting step** in heme synthesis and determines the overall production of heme. - This reaction occurs in the **mitochondria** and requires **pyridoxal phosphate (vitamin B6)** as a cofactor. *Lysine + succinyl CoA* - While succinyl CoA is a precursor, **lysine** is an essential amino acid involved in protein synthesis and other metabolic pathways, but not directly in heme synthesis. - The primary amino acid precursor for heme is **glycine**, not lysine. *Arginine + Malonyl CoA* - **Arginine** is involved in the urea cycle and nitric oxide synthesis, not heme synthesis. - **Malonyl CoA** is a key intermediate in **fatty acid synthesis**, not heme synthesis. *Glycine + Malonyl CoA* - **Glycine** is indeed a precursor for heme synthesis. - However, **malonyl CoA** is not involved in heme synthesis; rather, **succinyl CoA** is the correct coenzyme A derivative that condenses with glycine.

Q: What is the maximum daily degradation of hemoglobin in normal adults?

6 gm. ***6 gm*** - Approximately **6 grams of hemoglobin** are degraded daily in normal adults, primarily due to the breakdown of senescent red blood cells. - With an RBC lifespan of **120 days** and total body hemoglobin of approximately 750 grams, roughly **1% of RBCs are destroyed daily**. - This degradation process releases iron for reuse and converts the heme portion into **bilirubin**, which is then excreted. *2 gm* - This value is significantly **lower** than the actual amount of hemoglobin degraded daily. - Such a low degradation rate would imply a much longer red blood cell lifespan or a slower red blood cell turnover. *4 gm* - While closer, 4 grams is still an **underestimation** of the typical daily hemoglobin turnover in healthy adults. - This amount would not fully account for the normal destruction rate of roughly 1% of red blood cells per day. *8 gm* - This value is at the **upper limit** of normal daily hemoglobin degradation and is generally higher than the average in healthy individuals. - A persistent degradation of 8 grams or more might suggest an increased rate of **hemolysis** or other conditions leading to accelerated red blood cell destruction.

Q: Why is blood stored in citrate-phosphate-dextrose considered more beneficial for hypoxic patients compared to blood stored in acidic-citrate-dextrose?

The fall in 2,3-DPG is less.. ***The fall in 2,3-DPG is less.*** * **Citrate-phosphate-dextrose (CPD)** better preserves levels of **2,3-bisphosphoglycerate (2,3-DPG)** in stored red blood cells. * Higher 2,3-DPG levels are crucial for **oxygen unloading** from hemoglobin in tissues, which is particularly beneficial for hypoxic patients who need efficient oxygen delivery. *It has a higher pH level than acidic-citrate-dextrose.* * While CPD does maintain a **less acidic pH** than acid-citrate-dextrose (ACD), which is generally favorable for red blood cell viability, the most direct benefit for hypoxic patients relates to 2,3-DPG. * The slightly higher pH indirectly contributes to better 2,3-DPG preservation but isn't the primary reason for improved oxygen delivery. *It is more effective in oxygen delivery.* * While the *consequence* of using CPD is **more effective oxygen delivery** due to better 2,3-DPG preservation, this option describes the outcome rather than the underlying mechanism compared to the more specific answer regarding 2,3-DPG. * The increased efficacy in oxygen delivery is directly attributable to the preserved 2,3-DPG levels. *It has a longer shelf life than acidic-citrate-dextrose.* * The storage solutions primarily impact red blood cell viability and function, but the **shelf life** (typically 21-35 days depending on the anticoagulant/preservative) is generally determined by other factors, including the additive solutions used with the anticoagulant. * While CPD improves red blood cell quality, the primary advantage for hypoxic patients specifically lies in oxygen affinity rather than overall storage duration.

Question 1

A 25-year-old patient presents with cyanosis and is diagnosed with methemoglobinemia. What is the underlying biochemical mechanism responsible for this condition?

Accepted Answer

Oxidation of Fe2+ to Fe3+ in hemoglobin

Answer

Increased synthesis of hemoglobin

Answer

Reduction of Fe3+ to Fe2+ in hemoglobin

Answer

Decreased oxygen affinity of hemoglobin

Question 2

A mutation leads to a significant decrease in the cooperativity of hemoglobin for oxygen binding. Which allosteric regulator's interaction is most likely disrupted?

Accepted Answer

2,3-Bisphosphoglycerate

Answer

Carbon dioxide

Answer

Hydrogen ions

Answer

Carbon monoxide

Question 3

A patient with jaundice has elevated unconjugated bilirubin levels. Which enzyme is most likely deficient?

Accepted Answer

Glucuronyl transferase

Answer

Heme oxygenase

Answer

Biliverdin reductase

Answer

Heme synthase

Question 4

Which pigment is responsible for the greenish-black color of neonatal stool?

Accepted Answer

Biliverdin

Answer

Urochrome

Answer

Stercobilin

Answer

Bilirubin (yellow pigment)

Question 5

What is the approximate daily iron requirement for a healthy Indian male?

Accepted Answer

17 mg

Answer

10 mg

Answer

35 mg

Answer

5 mg

Question 6

Which of the following statements about coproporphyrin I and coproporphyrin III is correct?

Accepted Answer

In Dubin Johnson Syndrome, Coproporphyrin I in urine is 80% of the total coproporphyrin

Answer

Coproporphyrin I is not normally excreted in urine.

Answer

In Dubin Johnson Syndrome, total coproporphyrin levels are elevated.

Answer

Coproporphyrin III is primarily excreted in urine.

Question 7

What is the normal range of daily fecal urobilinogen excretion in healthy adults?

Accepted Answer

40-280 mg

Answer

100-200 mg

Answer

20-40 mg

Answer

50-300 mg

Question 8

Heme is synthesized from ?

Accepted Answer

Glycine + succinyl CoA

Answer

Lysine + succinyl CoA

Answer

Arginine + Malonyl CoA

Answer

Glycine + Malonyl CoA

Question 9

What is the maximum daily degradation of hemoglobin in normal adults?

Accepted Answer

6 gm

Answer

8 gm

Answer

2 gm

Answer

4 gm

Question 10

Why is blood stored in citrate-phosphate-dextrose considered more beneficial for hypoxic patients compared to blood stored in acidic-citrate-dextrose?

Accepted Answer

The fall in 2,3-DPG is less.

Answer

It has a higher pH level than acidic-citrate-dextrose.

Answer

It is more effective in oxygen delivery.

Answer

It has a longer shelf life than acidic-citrate-dextrose.

Hemoglobin and Iron Metabolism — MCQs

Hemoglobin and Iron Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?